Danish Medicines Agency inspections have been put on hold due to the COVID-19 pandemic.

That means the country’s domestic medical cannabis businesses could face further delays in getting product to market as producers await certificates of compliance from health agency.

The agency announced the measure at the end of March.

The Danish Medicines Agency issues certificates for cannabis-producing companies to confirm compliance with national regulations on the manufacture of cannabis products in the pilot program.

A certificate also confirms compliance with good manufacturing practices for medicines, which is needed before a company can export medical marijuana products to other markets in the European Union.

As of the end of 2019, Schroll Medical ApS and Canopy Growth Denmark ApS held licenses to produce cannabis bulk, as well as licenses to produce cannabis intermediate products (Cannabis primary products based on Danish-grown cannabis).

Rikke Jakobsen of the non-governmental organization Cannabis Denmark expects inspections to resume within two months.

Jakobsen said Denmark was one of the few countries in Europe which took early action to deal with the virus.

“We expect a gradual reopening over the summer,” she said.

As of April 14, the country reported 6,511 infections and 299 deaths from the new coronavirus.

The country took the first steps to reopen parts of society recently, though some measures were extended into May.

A ban on major events was pushed to Aug. 31.

Denmark’s four-year medical marijuana program launched in 2018, and a formal evaluation is required to take place in 2020.

The number of patients accessing the pilot program nearly halved in the third quarter of 2019 after Canadian producer CannTrust ran into regulatory issues.

Unique consumers fell to 582 in the July-September period from 1,045 in the April-June quarter.

Matt Lamers is Marijuana Business Daily’s international editor, based near Toronto. He can be reached at [email protected].

Pure CBD Hemp Oil

• Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

• Clinically proven therapeutic effects.

• Relieves anxiety and stress

• Eliminates chronic pain and aches

• Regulates mood and sleep patterns

• Enhances focus and clarity
  
  
  

addiitional information, George Scorsis website
Originally posted on via Cannabis Industry News